Reovirus μ1 Protein Affects Infectivity by Altering Virus-Receptor Interactions.
Proteins that form the reovirus outer capsid play an active role in the entry of reovirus into host cells. Among these, the σ1 protein mediates attachment of reovirus particles to host cells via interaction with cell surface glycans or the proteinaceous receptor junctional adhesion molecule A (JAM-A). The μ1 protein functions to penetrate the host cell membrane to allow delivery of the genome-containing viral core particle into the cytoplasm to initiate viral replication. We demonstrate that a reassortant virus that expresses the M2 gene-encoded μ1 protein derived from prototype strain T3D in an otherwise prototype T1L background (T1L/T3DM2) infects cells more efficiently than parental T1L. Unexpectedly, the enhancement in infectivity of T1L/T3DM2 is due to its capacity to attach to cells more efficiently. We present genetic data implicating the central region of μ1 in altering the cell attachment property of reovirus. Our data indicate that the T3D μ1-mediated enhancement in infectivity of T1L is dependent on the function of σ1 and requires the expression of JAM-A. We also demonstrate that T1L/T3DM2 utilizes JAM-A more efficiently than T1L. These studies revealed a previously unknown relationship between two nonadjacent reovirus outer capsid proteins, σ1 and μ1.


OBJECTIVE
How reovirus attaches to host cells has been extensively characterized. Attachment of reovirus to host cells is mediated by the σ1 protein, and properties of σ1 influence the capacity of reovirus to target specific host tissues and produce disease. Here, we present new evidence indicating that the cell attachment properties of σ1 are influenced by the nature of μ1, a capsid protein that does not physically interact with σ1. These studies could explain the previously described role for μ1 in influencing reovirus pathogenesis. These studies are also of broader significance because they highlight an example of how genetic reassortment between virus strains could produce phenotypes that are distinct from those of either parent.
Department of Biology, Indiana University, Bloomington, Indiana, USA.
Deepti
D
Thete
Department of Biology, Indiana University, Bloomington, Indiana, USA.
Anthony J
AJ
Snyder
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Bernardo A
http://orcid.org/0000-0002-7721-183X
BA
Mainou
Department of Biology, Indiana University, Bloomington, Indiana, USA pdanthi@indiana.edu.
Pranav
P
Danthi
D000818:Animals; D036022:Capsid Proteins / Q000235:genetics / Q000502:physiology*; D015815:Cell Adhesion Molecules / Q000502:physiology; D002460:Cell Line; D054884:Host-Pathogen Interactions / Q000235:genetics / Q000502:physiology; D012089:Mammalian orthoreovirus 3 / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D051379:Mice; D030102:Orthoreovirus, Mammalian / Q000235:genetics / Q000472:pathogenicity / Q000502:physiology; D011956:Receptors, Cell Surface / Q000502:physiology; D011991:Receptors, Virus / Q000502:physiology; D012088:Reoviridae Infections / Q000209:etiology / Q000821:virology; D014774:Virulence / Q000235:genetics / Q000502:physiology; D053585:Virus Attachment
D036022:Capsid Proteins; D015815:Cell Adhesion Molecules; C498686:F11r protein, mouse; D011956:Receptors, Cell Surface; D011991:Receptors, Virus; C055356:mu1 protein, Reovirus; C046176:reovirus type 3 receptor; C031728:sigma 1 protein, reovirus
J Cell Biol. 1993 Sep;122(5):1023-41
8394844
Cell. 2001 Feb 9;104(3):441-51
11239401
EMBO J. 2008 Apr 23;27(8):1289-98
18369316
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16496-501
17053074
J Virol. 2006 Feb;80(3):1261-70
16415003
Nat Rev Microbiol. 2016 Jul;14 (7):448-60
27211789
PLoS Pathog. 2008 Dec;4(12):e1000248
19112493
Curr Protoc Microbiol. 2009 Aug;Chapter 15:Unit15C.1
19653214
J Virol. 1988 Jan;62(1):246-56
3275434
J Virol. 2002 Oct;76(19):9920-33
12208969
Proc Natl Acad Sci U S A. 1982 Feb;79(4):1298-302
6951176
J Exp Med. 1980 Oct 1;152(4):853-68
7420022
J Virol. 2006 Sep;80(17):8422-38
16912293
J Virol. 1995 Nov;69(11):6972-9
7474116
Structure. 2005 Oct;13(10):1545-57
16216585
Virology. 1963 Jan;19:58-65
13929839
J Immunol. 1981 Oct;127(4):1697-701
6974200
J Virol. 1993 Sep;67(9):5339-45
8350400
J Biol Chem. 2007 Jun 15;282(24):17930-40
17452315
J Virol. 2002 Feb;76(3):1051-61
11773381
Virology. 1969 Dec;39(4):791-810
4311639
J Virol. 2009 Jul;83(14):7004-14
19439475
J Virol. 1997 Mar;71(3):2540-6
9032397
J Virol. 2010 Dec;84(24):12723-32
20943982
Virology. 2007 May 10;361(2):412-25
17208266
J Virol. 2015 Apr;89(8):4319-34
25653434
Cell. 2002 Jan 25;108(2):283-95
11832217
J Virol. 2008 Jan;82(1):161-72
17959662
J Virol. 2011 Jan;85(1):296-304
20980509
J Virol. 2000 Apr;74(7):2981-9
10708412
J Virol. 1991 Dec;65(12):6772-81
1719233
Virology. 1989 Sep;172(1):382-5
2773327
PLoS Pathog. 2008 Dec;4(12):e1000235
19079583
J Virol. 2012 Apr;86(7):3466-73
22278245
Virology. 1994 Jun;201(2):303-11
8184540
J Virol. 2015 Jun;89(11):6136-40
25810543
Virology. 2010 Mar 15;398(2):194-200
20042210
J Virol. 2013 Dec;87(24):13532-42
24089575
Virology. 2003 Jan 5;305(1):25-30
12504537
J Virol. 2006 Mar;80(6):2760-70
16501085
J Virol. 2003 Dec;77(24):13361-75
14645591
Cell Host Microbe. 2014 Jun 11;15(6):681-91
24922571
Virology. 1981 Jan 15;108(1):156-63
7269235
J Infect Dis. 1980 May;141(5):609-16
6989930
J Virol. 1996 Nov;70(11):7984-91
8892922
J Virol. 1985 Nov;56(2):356-64
4057353
J Immunol. 1980 May;124(5):2143-8
7365250
Curr Top Microbiol Immunol. 2010;343:91-119
20397070
J Virol. 1997 Jan;71(1):299-306
8985350
PLoS Pathog. 2011 Aug;7(8):e1002166
21829363
PLoS Pathog. 2012;8(12):e1003078
23236285
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5744-8
271999
J Virol. 2005 Jul;79(13):7967-78
15956543
J Virol. 1985 Nov;56(2):613-6
4057359
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19986-91
19897716
J Biol Chem. 2001 Jan 19;276(3):2200-11
11054410